Researchers warn against use of transfusions for trial eligibility

10/21/2010 | MedPage Today (free registration)

Canadian researchers have reported three cases involving patients who underwent blood transfusions in order to qualify as participants for trials of new cancer drugs. The researchers have expressed concern over the practice, citing the risks associated with transfusions, and are recommending that all other options -- such as using anemia treatments -- be exhausted first before resorting to blood transfusions.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC